NYLI Healthy Hearts ETF HART

Medalist Rating as of | See New York Life Investment Hub

Morningstar’s Analysis HART

Will HART outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong management team and sound investment process underpin NYLI Healthy Hearts ETF's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HART

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 48.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Alphabet Inc Class A

5.19 468,908
Communication Services

Abbott Laboratories

5.09 459,918
Healthcare

Pfizer Inc

5.01 453,387
Healthcare

UnitedHealth Group Inc

5.01 453,224
Healthcare

Apple Inc

5.01 453,099
Technology

Johnson & Johnson

4.96 448,064
Healthcare

Novartis AG Registered Shares

4.83 436,604
Healthcare

Eli Lilly and Co

4.68 422,781
Healthcare

AstraZeneca PLC

4.56 412,363
Healthcare

Novo Nordisk AS Class B

4.32 390,635
Healthcare

Sponsor Center